SOUTHWEST ONCOLOGY GROUP TRIAL S9912: INTRAPERITONEAL CISPLATIN AND PACLITAXEL PLUS INTRAVENOUS PACLITAXEL AND PEGYLATED LIPOSOMAL DOXORUBICIN AS PRIMARY CHEMOTHERAPY OF SMALL-VOLUME RESIDUAL STAGE III OVARIAN CANCER

OBJECTIVE: While primary cisplatin-based intraperitoneal chemotherapy has been shown to favorably impact survival in small-volume residual advanced ovarian cancer, there is a need to develop strategies that improve the effectiveness of this approach. METHODS: A multi-center phase 2 trial was conduct...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Smith, Harriet O., Moon, James, Wilczynski, Sharon P., Tiersten, Amy D., Hannigan, Edward V., Robinson, William R., Rivkin, Saul E., Anderson, Garnet L., Liu, P.Y., Markman, Maurie
Médium: Artigo
Jazyk:Inglês
Vydáno: 2009
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2703693/
https://ncbi.nlm.nih.gov/pubmed/19464730
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2009.04.023
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky